Is DHR stock a Buy, Sell, or Hold?

Based on our analysis, DHR is currently a WAIT with low confidence. 📊 MIXED SIGNALS: DHR shows conflicting indicators. Wait for confirmation before entering.

What is the fair value of DHR stock?

Our analysis estimates the fair value range for DHR to be between $213.29 and $227.73. The current price is $230.50.

What is the analyst price target for DHR?

The average Wall Street analyst price target for DHR is $258.86. This implies a potential upside of 12.3% from current levels.

Danaher (DHR) Stock: Buy, Sell, or Hold?

DHR - Danaher Corporation

INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL

$230.50

0.75 (0.33%) ▲

5d: +0.64%

30d: +3.01%

90d: +17.3%

WAIT

LOW Confidence

Protect Your DHR Gains

Analysis Updated: Oct 23, 2026 12:00 AM ET

Earnings: Oct 21, 2026 0d

Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Oct 20, 2026 at $224.24 · last confirmed Oct 23, 2026

Strength: 3.6/10

Get Alerted When DHR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 MIXED SIGNALS: DHR shows conflicting indicators. Wait for confirmation before entering.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 8.8%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$287.26

Based on 6.4% avg growth

INTRINSIC VALUE TODAY

$178.36

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.6x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: DHR is currently trading at $230.50, which is considered extended relative to its 30-day fair value range of $213.29 to $227.73. The stock's valuation (Forward PE: 24.7) is in line with its historical norms (22.6). At these levels, the market is pricing in 3.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, DHR is in a strong uptrend. Immediate support is located at $217.55, while resistance sits at $238.13.

Market Sentiment: DHR scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $258.86 (+12.3%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED

Historical Trading Range $213.29 - $227.73

Company Quality Score 45/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 27.1%

Protect Your Profits

Holding DHR? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BEARISH: Price extended above range
BEARISH: Weak technical setup (31/100)
BULLISH: High volume confirmation
BULLISH: Trading below Wall St target ($258.86)
NEUTRAL: Market pricing in 3.0% annual earnings growth - fairly valued
WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $213.29 - $227.73

Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $217.55

Resistance Level $238.13

Current Trend Strong Uptrend

Technical data as of Oct 23, 2026

Fundamental Context

Forward P/E (Next Year Est.) 24.71

Wall Street Target $258.86 (+12.3%)

Revenue Growth (YoY) 8.3%

Earnings Growth (YoY) 37.8%

Profit Margin 16.9%

Valuation Premium vs History +3.0% premium

PE vs Historical 24.7 vs 22.6 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): +3.0% (market-implied from PE analysis)

1-Year Target $237.42 (+3%)

2-Year Target $244.54 (+6%)

3-Year Target $251.87 (+9%)

3-Yr Target (if PE normalizes) (PE: 25→23) PE COMPRESSION $230.33 (0%)

Earnings growth offset by PE compression

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 24.7, Growth: 8.8%) $296.60 (+29%)

Base: (SPY PE: 19.9, Growth: 8.8%) $238.34 (+3%)

Bear: (PE: 16.9, Growth: 8.8%) $202.59 (-12%)

📈 Valuation based on Current Earnings

RECOVERY PLAY: Stock looks expensive now (39x PE), but valuation improves significantly next year (25x PE) as earnings recover.

Trailing PE: 38.72 | Current EPS (TTM): $6.04

Bull Case $396.20 (+72%)

Analyst growth 54.0%, PE expands to 42.6

Base Case $360.18 (+57%)

Market implied 54.0%, PE stable at 38.7

Bear Case $159.02 (-31%)

Severe decline -20.0%, PE contracts to 32.9

These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: October 23, 2026 5:33 PM ET
Data refreshes hourly during market hours. Next update: 6:33 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is DHR showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for DHR.

Create Free Account

Already have an account? Log In

Featured in Portfolios

DHR is a key holding in these high-performance investment strategies.

Healthcare Giants Sector • +24.8% Return

View All Strategies

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
GH Guardant Health Inc	STRONG BUY 26 analysts	$202	67 BUY
TMO Thermo Fisher Scientific…	STRONG BUY 28 analysts	$691	48 HOLD
EXAS EXACT Sciences Corporati…	STRONG BUY 26 analysts	$106	52 HOLD
NTRA Natera Inc	STRONG BUY 23 analysts	$404	54 HOLD
IQV IQVIA Holdings Inc	STRONG BUY 22 analysts	$299	50 HOLD

GH Guardant Health I…

67 BUY

TMO Thermo Fisher Sci…

48 HOLD

EXAS EXACT Sciences Co…

52 HOLD

NTRA Natera Inc

54 HOLD

IQV IQVIA Holdings Inc

50 HOLD

Advanced DHR Option Strategies

Professional options setups generated by AI based on today's DHR price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for DHR

DHR Technical Chart DHR Price Prediction DHR Earnings Date DHR Investment Advisor DHR Fair Price Analyzer DHR Options Advisor DHR Options Chain DHR Options Analysis DHR Competitors

Compare DHR with Peers

DHR vs TMO
Which one to buy?

DHR vs SYK
Which one to buy?

DHR vs BDX
Which one to buy?

DHR vs ZTS
Which one to buy?

DHR vs ECL
Which one to buy?

DHR vs SENS

DHR vs RAL
Winner: DHR

DHR vs IQV
Winner: DHR

Create New Comparison View All Competitors

Tradestie